Vikas Kumar

Dr. Vikas Kumar

Biotechnology, Chandigarh University, Mohali, India
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RSRakshandha Saini
Rakshandha Saini
NSNitin Sharma
Nitin Sharma
OOOluwole Solomon Oladeji
Oluwole Solomon Oladeji
ASAnuradha Sourirajan
Anuradha Sourirajan
KDKamal Dev
Kamal Dev
VKVikas Kumar
Vikas Kumar

1 November 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
PNPrakriti Nidhi
Prakriti Nidhi
RRRajan Rolta
Rajan Rolta
VKVikas Kumar
Vikas Kumar
KDKamal Dev
Kamal Dev
ASAnuradha Sourirajan
Anuradha Sourirajan

15 July 2021 in Current Pharmacology Reports
Verified
Journal Article
Closed access
PDF file
RRRajan Rolta
Rajan Rolta
DSDeeksha Salaria
Deeksha Salaria
PSPremPrakash Sharma
PremPrakash Sharma
BSBhanu Sharma
Bhanu Sharma
VKVikas Kumar
Vikas Kumar
KDKamal Dev
Kamal Dev

12 August 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Hailemeleak Regassa MorcaHailemeleak Regassa Morca
Hailemeleak Regassa Morca
ASAnuradha Sourirajan
Anuradha Sourirajan
VKVikas Kumar
Vikas Kumar
SPSadanand Pandey
Sadanand Pandey
Deepak KumarDeepak Kumar
Deepak Kumar
KDKamal Dev
Kamal Dev
Cancer is a serious and significantly progressive disease. Next to cardiovascular disease, cancer has become the most common cause of mortality in the entire world. Several factors, such as environmental factors, habitual activities, genetic factors, etc., are responsible for cancer. Many cancer patients seek alternative and/or complementary treatments because of the high death rate linked with cancer and the adverse side effects of chemotherapy and radiation therapy. Traditional medicine has a long history that begins with the hunt for botanicals to heal various diseases, including cancer. In the traditional medicinal system, several plants used to treat diseases have many bioactive compounds with curative capability, thereby also helping in disease prevention. Plants also significantly contributed to the modern pharmaceutical industry throughout the world. In the present review, we have listed 33 medicinal plants with active and significant anticancer activity, as well as their anticancer compounds. This article will provide a basic set of information for researchers interested in developing a safe and nontoxic active medicinal plant-based treatment for cancer. The research will give a scientific foundation for the traditional usage of these medicinal herbs to treat cancer.

1 January 2018 in Journal of Traditional and Complementary Medicine
Verified
Journal Article
Open access
VKVikas Kumar
Vikas Kumar
NSNitin Sharma
Nitin Sharma
ASAnuradha Sourirajan
Anuradha Sourirajan
PKPrem Kumar Khosla
Prem Kumar Khosla
KDKamal Dev
Kamal Dev
The present study was aimed to evaluate the antimicrobial and antioxidant potential of ethanolic extract and its different solvent fractions (chloroform, ethyl acetate, n-butanol and aqueous fraction) of bark and leaves of Terminalia arjuna. The antimicrobial activity was determined by disc diffusion and minimum inhibitory concentration (MIC) methods against six bacterial stains. The antioxidant activity was evaluated by using DPPH, FRAP and Nitric oxide (NO) scavenging assay. The total phenolics and flavonoid content were found to be higher in n-butanolic fraction of bark (294.6 ± 8.1 mg/g GAE and 168.6 ± 12.3 mg/g RE, respectively) and leaves (203.7 ± 7.0 mg/g GAE and 144.8 ± 11.1 mg/g RE, respectively). The maximum antimicrobial activity was shown by n-butanolic fraction of bark and leaves. The zone of inhibition of 15.0 ± 0.7 mm, 15.5 ± 0.7 mm, 15.0 ± 1.5 mm, 15.5 ± 0.7 mm, 15.0 ± 0.7 mm, 15.0 ± 0.7 mm was observed against Bacillus subtilis, Staphylococcus aureus, Eschericia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Salmonella typhi respectively. In case of leaves extract, zone of inhibition of 13.5 ± 0.7 mm, 16.5 ± 0.7 mm, 14.0 ± 0.5 mm, 15.0 ± 0.5 mm, 13.5 ± 0.7 mm, 14.0 ± 0.7 mm was observed against B. subtilis, S. aureus, E. coli, K. pneumoniae, P. aeruginosa, S. typhi, respectively. The n-butanol fraction of bark [IC50-4.1 μg/ml (DPPH), 21.0 μM (FRAP), 3.3 μg/ml (NO)] and leaves [IC50-4.8 μg/ml (DPPH), 28.9 μM (FRAP), 3.2 μg/ml (NO)] showed more antioxidant potential as compared to that of crude ethanolic extract, ethyl acetate fraction, chloroform fraction, aqueous fraction and even ascorbic acid. These results clearly indicated comparative antioxidant potential and antimicrobial activity in extracts of bark and leaves of T. arjuna.

1 July 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RRRajan Rolta
Rajan Rolta
VKVikas Kumar
Vikas Kumar
ASAnuradha Sourirajan
Anuradha Sourirajan
NUNavneet Kumar Upadhyay
Navneet Kumar Upadhyay
KDKamal Dev
Kamal Dev